Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy.

导出 OA

翻译打印收藏纠错

作者： David,Gachoud ^[1] ; Claire,Bertelli ^[2] ; Nathalie,Rufer ^[3]

作者单位： Department of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. ^[1] Medical Education Unit, School of Medicine, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. ^[2] Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. ^[3] Interregional Blood Transfusion SRC, Epalinges, Switzerland. ^[4] Department of Oncology, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland. ^[5]

关键词 COVID-19 convalescent plasma SARS-CoV-2 viral loads anti-CD20 therapy immunocompromised

主题词人类(Humans);免疫法, 被动(Immunization, Passive);B-淋巴细胞(B-Lymphocytes);抗体, 病毒(Antibodies, Viral);抗体, 中和(Antibodies, Neutralizing)

DOI 10.1111/bjh.18540

PMID 36354067

发布时间 2023-02-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交